Skip to main content

Advertisement

Log in

All-trans-retinoic acid suppresses interferon-γ and tumor necrosis factor-α; a possible therapeutic agent for rheumatoid arthritis

  • Original Article
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

Objectives: To study the effects of all-trans-retinoic acid (ATRA), we determined the proliferation and cytokine production by peripheral blood mononuclear cells (PBMCs) and CD4+ T cells in healthy volunteers and patients with rheumatoid arthritis (RA), and explored the possibility of using ATRA as a therapeutic agent for autoimmune diseases. Methods: Proliferation of these cells was determined by modified MTT assay, and expression of CC chemokine receptors 4 (CCR4) and CCR5 was determined by flow cytometry. Production and expression of interferon (IFN)-γ, interleukin (IL)-2, IL-4, and tumor necrosis factor (TNF)-α was determined by Enzyme-Linked Immunosorbent Assay (ELISA) and reverse transcription-polymerase chain reaction (RT-PCR). The presence of STAT6 protein was determined by Western blot analysis. Results: ATRA did not affect the proliferation or production of IL-2 and IL-4. We did not detect STAT6 protein, and saw no evidence of the differentiation of PBMCs to Th1 or Th2 cells. In contrast, ATRA suppressed the production of IFN-γ and TNF-α significantly. There were no significant differences between the healthy volunteers and RA patients. Conclusions: ATRA was demonstrated to affect the cytokine production of IFN-γ and TNF-α. ATRA might be useful in the treatment of autoimmune diseases such as RA.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1 Effects
Fig. 2 Time
Fig. 3 Effects
Fig. 4 Effects
Fig. 5 Effects

Similar content being viewed by others

References

  1. Romagnani S (1995) Biology of human TH1 and TH2 cells. J Clin Immunol 15:121–129

    Article  PubMed  CAS  Google Scholar 

  2. Hayashi M, Martinez OM, Garcia-Kennedy (1995) Expression of cytokines and immune mediators during chronic liver allograft rejection. Transplantation 60:1538–1553

    Article  Google Scholar 

  3. Lafaille JJ (1998) The role of helper T cell subset in autoimmune disease. Cytokine Growth Factor Rev 9:139–151

    Article  PubMed  CAS  Google Scholar 

  4. Barton MT, Vitetta ES (1990) Interleukin-4 induces changes in the chromatin structure of the Ig switch region in resting B cells before switch recombination. J Exp Med 172:375–378

    Article  PubMed  Google Scholar 

  5. Ichiki T, Takahashi W, Watanabe T (1993) Regulation of the expression of human C germline transcript. J Immunol 150:5408–5417

    PubMed  CAS  Google Scholar 

  6. Feldmann M, Brennan FM, Maini RN (1996) Role of cytokines in rheumatoid arthritis. Annu Rev Immunol 14:397–440

    Article  PubMed  CAS  Google Scholar 

  7. Feldmann M, Brennan FM, Maini RN (1996) Rheumatoid arthritis. Cell 85:307–310

    Article  PubMed  CAS  Google Scholar 

  8. Mathew JS, Sharma RP (2000) Effect of all-trans-retinoic acid on cytokine production in a murine macrophage cell line. Int J Immunopharmacol 22:693–706

    Article  PubMed  CAS  Google Scholar 

  9. Keffer J, Probert L, Cazlaris H, Georgopoulos S, Kaslaris E, Kioussis D, Kollias G (1991) Transgenic mice expressing human tumor necrosis factor: a predictive genetic model of arthritis. EMBO J 10:4025–4031

    PubMed  CAS  Google Scholar 

  10. Ishiyawa M, Hideyuki T, Shiga M (1996) A combined assay of cell viability and in vitro cytotoxity with a highly water-soluble tetrazolium salt, neutral red and crystal violet. Biol Pharm Bull 19:1518–1520

    PubMed  Google Scholar 

  11. Diefenbach A, Schindler H, Rollinghoff M, Yokoyama WM, Bogdan C (1999) Requirement for type 2 NO synthase for IL-12 signaling in innate immunity. Science 284:951–955

    Article  PubMed  CAS  Google Scholar 

  12. Jiang XL, Dillehay DL, Everson MP, Tilden AB, Lamon EW (1992) Potentiation of IL-2-induced T-cell proliferation by retinoids. Int J Immunopharmacol 14:195–204

    Article  PubMed  CAS  Google Scholar 

  13. Sidell N, Ramsdell F (1988) Retinoic acid upregulates interleukin-2 receptors on activated human thymocytes. Cell Immunol 115:299–309

    Article  PubMed  CAS  Google Scholar 

  14. Felli MP, Vacca A, Meco D, Screpanti I, Farina AR, Maroder M, Martinotti S, Petrangeli E, Frati L, Gulino A (1991) Retinoic acid-induced down-regulation of the interleukin-2 promoter via cis-regulatory sequences containing an octamer motif. Mol Cell Biol 11:4771–4778

    PubMed  CAS  Google Scholar 

  15. Kinoshita K, Yoo BS, Nozaki Y, Sugiyama M, Ikoma S, Ohno M, Funauchi M, Kanamaru A (2003) Retinoic acid reduces autoimmune renal injury and increases survival in NZB/WF1 mice. J Immunol 170:5793–5798

    PubMed  CAS  Google Scholar 

  16. Racke MK, Burnett D, Pak SH, Albert PS, Cannella B, Raine CS, McFarlin DE, Scott DE (1995) Retinoid treatment of experimental allergic encephalomyelitis. IL-4 production correlates with improved disease course. J Immunol 154:450–458

    PubMed  CAS  Google Scholar 

  17. Kaplan MH, Schindler U, Smiley ST, Grusby MJ (1996) Stat6 is required for mediating responses to IL-4 and for development of Th2 cells. Immunity 4:313–319

    Article  PubMed  CAS  Google Scholar 

  18. Konta T, Xu Q, Furusu A, Nakayama K, Kitamura M (2001) Selective roles of retinoic acid receptor and retinoid X receptor in the suppression of apoptosis by all-trans-retinoic acid. J Biol Chem 16:12697–12701

    Article  Google Scholar 

  19. Siebenlist U, Franzoso G, Brown K (1994) Structure, regulation and function of NF-κB. Annu Rev Cell Biol 10:405–455

    Article  PubMed  CAS  Google Scholar 

  20. Gerli R, Bistoni O, Russano A, Fiorucci S, Borgato L, Cesarotti ME, Lunardi C (2002) In vivo activated T cells in rheumatoid synovitis. Analysis of Th1- and Th2-type cytokine production at clonal level in different stages of disease. Clin Exp Immunol 129:549–555

    CAS  Google Scholar 

  21. Steiner G, Tohidast-Akrad M, Witzmann G, Vesely M, Studnicka-Benke A, Gal A, Kunaver M, Zenz P, Smolen JS (1999) Cytokine production by synovial T cells in rheumatoid arthritis. Rheumatology 38:202–213

    Article  PubMed  CAS  Google Scholar 

  22. Canete JD, Martinez SE, Farres J, Sanmarti R, Blay M, Gomez A, Salvador G, Munoz-Gomez J (2000) Differential Th1/Th2 cytokine patterns in chronic arthritis: interferon gamma is highly expressed in synovium of rheumatoid arthritis compared with seronegative spondyloarthropathies. Ann Rheum Dis 59:263–268

    Article  PubMed  CAS  Google Scholar 

  23. Dayer JM (2002) Interleukin 1 or tumor necrosis factor-alpha: which is the real target in rheumatoid arthritis? J Rheumatol 65:10–15

    CAS  Google Scholar 

  24. Bathon JM, Martin RW, Fleischmann RM et al (2000) A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis. N Engl J Med 343:1586–1593

    Article  PubMed  CAS  Google Scholar 

  25. Hallegua DS, Weisman MH (2002) Potential therapeutic uses of interleukin 1 receptor antagonists in human diseases. Ann Rheum Dis 61:960–967

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgment

We are grateful to K. Niki and K. Furukawa for their excellent technical assistance.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Masanori Funauchi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nozaki, Y., Tamaki, C., Yamagata, T. et al. All-trans-retinoic acid suppresses interferon-γ and tumor necrosis factor-α; a possible therapeutic agent for rheumatoid arthritis. Rheumatol Int 26, 810–817 (2006). https://doi.org/10.1007/s00296-005-0076-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-005-0076-1

Keywords

Navigation